India, Nov. 2 -- Conavi Medical Corp. (CNVI.V), a commercial-stage medical device company, on Monday announced the completion of the first U.S. placement of OCTIV, a hybrid intravascular imaging system used in guiding minimally invasive cardiovascular procedures in patients with coronary artery disease.
OCTIV was derived from the company's Novasight technology and combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) in a single imaging catheter used to visualize coronary arteries from multiple angles. The technique can further be utilized to guide percutaneous coronary intervention (PCI) following an assessment of the disease extent.
The use of OCTIV in a clinical setting was carried out by interventional cardio...